首页> Annals of oncology : official journal of the European Society for Medical Oncology> MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.

MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.

导出原文传递

翻译打印收藏纠错

第一作者： U B,Patel

第一单位： Radiology Department, London North-West Healthcare NHS Trust, London.

作者： U B,Patel ^[1] ; G,Brown ^[2] ; I,Machado ^[3] ; J,Santos-Cores ^[4] ; C,Pericay ^[5] ; E,Ballesteros ^[6] ; A,Salud ^[5] ; M,Isabel-Gil ^[7] ; C,Montagut ^[8] ; J,Maurel ^[5] ; J,Ramón-Ayuso ^[9] ; N,Martin ^[10] ; R,Estevan ^[11] ; C,Fernandez-Martos ^[12]

作者单位： Radiology Department, London North-West Healthcare NHS Trust, London. ^[1] Radiology Department, The Royal Marsden Hospital NHS Foundation Trust, London, UK. ^[2] Department of Pathology, Valencia Institute of Oncology, Valencia, Spain ^[3] Department of Radiology, Fundacion InstitutoValenciano de Oncologia, Valencia, Spain ^[4] Department of Medical Oncology, Corporació Sanitària Parc Taulí, Parc Taulí, 1, Sabadell, Barcelona, Spain. ^[5] Department of Radiology, Corporación Sanitaria Parc Taulí, Sabadell, Barcelona, Spain. ^[6] Department of Radiology, Hospital Universitari Arnau de Vilanova, Lleida. ^[7] Department of Medical Oncology Department, Hospital del Mar, Barcelona. ^[8] Department of Radiology, Hospital Clinic de Barcelona, Barcelona. ^[9] Department of Pivotal, Madrid, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain. ^[10] Department of Surgery, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain. ^[11] Department of Medical Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain. ^[12]

关键词 MRI extramural venous invasion primary chemotherapy rectal cancer